| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.15 | 0.3 |